ArticleCancers2022
CRIF1-CDK2 Interface Inhibitors Enhance Taxol Inhibition of the Lethal Triple-Negative Breast Cancer.
Xiaoye Sang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it
ArticleCancers2022
Xiaoye Sang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.